Profound Medical

Update in progress

PROF (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Profound Medical Corp. is a commercial-stage medical device company developing AI-powered, MRI-guided, incision-free therapies for image-guided tissue ablation. Its lead system, TULSA-PRO, uses MRI with robotically driven transurethral ultrasound and closed-loop temperature control to ablate prostate tissue, whole gland or targeted regions. Its Sonalleve platform combines real-time MRI and thermometry for fibroids, adenomyosis, bone metastases palliation, and benign tumors. It operates in Canada, Germany, the US, China, and Finland and is based in Mississauga, Canada.

Company score

Sentiment: 0.36; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.13; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.09; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.06; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.21; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive

Company

MarketNasdaqCM (NCM)
LocationCanada
CEODr. Arun Swarup Menawat MBA, Ph.D.
Employees162
Websitewww.profoundmedical.com

Identifiers

ISINCA74319B5027
FIGIBBG00CXJY8L7
CUSIP74319B502
CIK0001628808